SOMERSET, N.J.--(BUSINESS WIRE)--Apicore LLC announced today that the U.S. Food and Drug Administration (FDA) completed an inspection of its kilo-scale API manufacturing site in Somerset, New Jersey from December 12, 2008 to December 15, 2008, according to Compliance Program 7356.002F, “Drug Manufacturing Inspections for Bulk Pharmaceutical Chemicals.” This was the second successful inspection of the site since 2006.
